Mebeverine Extended Release Pellets-Suitable for filling in 135mg & 200mg Capsules.
MKPPL achieved the desired sustained release profile equivalent to innovator
Mebeverine is an antispasmodic medicine which is taken to relieve bloating and cramp pain in the lower abdomen. These symptoms are commonly associated with the gastrointestinal condition called irritable bowel syndrome.
MKPPL aims to deliver Mebeverine as an inhibitor of calcium-depot replenishment. Musculotropic compounds act directly on the gut muscles at the cellular level to relax them. This relieves painful muscle spasms of the gut without affecting its normal motility.
Offer complete technical package for registrations in all regulated/semi regulated markets.
Mesalamine Pellets / Granules / Premix
Mesalamine Pellets 70% – Suitable for Capsules (Dose: 500 mg)
Mesalamine is a drug used for treating ulcerative colitis. Although the exact mechanism of mesalamine is not known it is believed to be reducing the inflammation in the colon through systemic action.
Mesalamine is an anti-inflammatory agent used to treat ulcerative colitis. Mesalamine comes as a Delayed-release tablet, Delayed-release capsule, Controlled-release capsule, Extended-release capsule, Suppositories.
Mesalamine ER Pellets have dissolution time of 8 hours and are released as per the USP Monograph.
We do offer development services in case of a requirement for different formulation/dosage/strength
Offer complete technical package for registrations in all regulated/semi regulated markets
Products protected by ongoing Patents are not offered by MKPPL.